Pharmaceutical CAS 25122-46-7 Clobetasol Propionate Raw Material Clobetasol Propionate Powder Clobetasol Propionate

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Clobetasol Propionate
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >99%
• Product Name: Clobetasol Propionate
• Name: Clobetasol Propionate Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 25122-46-7
• Mf: C25h32clfo5
• MW: 466.97
• Melting Point: 195.5 C
• Density: 1.28
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 1000kg/Month

Product Description

Pharmaceutical CAS 25122-46-7 Clobetasol Propionate Raw Material Clobetasol Propionate Powder Clobetasol Propionate

Product Description

Product Details

Product name	Clobetasol Propionate
Cas number	25122-46-7
Appearance	White powder
MF	C25H32ClFO5
MW	466.974

Clobetasol propionate is a corticosteroid used to treat various skin disorders including eczema and psoriasis. It is also highly effective for  contact dermatitis caused by exposure to poison ivy/oak. Clobetasol belongs to US Class I (Europe: class IV) of the corticosteroids, making it one of the most potent available.It comes in shampoo,mousse,ointment and emollient cream presentations. It has very high potency and typicallyshould not be used with occlusive dressings, or for extended continuous use(beyond two weeks). It is also used to treat several autoimmune 
diseases including alopecia areata, vitiligo and lichen planus (auto immune skin nodules).

Application&Function

Adrenocorticotropic hormone drugs, anti-inflammatory, anti-allergic and anti-drug more effective than prednison, and promoting the removal of potassium sodium retention is very 
light, intramuscular or intravenous pituitary - adrenal strong inhibition:
1. Anti-inflammatory effects: The product can reduce and prevent tissue response to inflammation, thereby reducing inflammation performance. Hormone suppression of inflammatory cells, including leukocytes and macrophages accumulation in sites of inflammation and inhibition of phagocytosis, lysosomal enzyme release and synthesis and release of inflammatory chemical mediators. Can reduce and prevent tissue response to inflammation, thereby reducing inflammation performance. 
2. Immunosuppressive effect: preventing or inhibiting cell-mediated immune response, delayed hypersensitivity reactions, reducing T lymphocytes, monocytes, eosinophils, reducing immunoglobulin binding to cell surface receptors and inhibition of the synthesis and release of interleukin, thus reducing the T lymphocyte transformation of lymphoblastoid cells, and reduce the extension of the primary immune response. Can reduce immune complexes through the basement membrane, and can reduce the concentration of ingredients complement and immunoglobulins.

Specification